Results 211 to 220 of about 13,011 (272)

A clinical-stage oncology compound selectively targets drug-resistant cancers

Long K, Bhattacharjee D, Newman-Stonebraker SH, Suhr S, Mercado BQ, Tighe A, Romero L, Thompson SL, Sausville EL, John KM, Julian L, Mishra S, Klingbeil O, Gupta P, Bhatt U, Gao AC, Ricardo S, Vakoc CR, Bornhauser BC, Corsello SM, Taylor SS, Holland PL, Sheltzer JM.   +22 more
europepmc   +1 more source

Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction. [PDF]

Theranostics
Ovejero S, Alibert L, Devin J, Cañeque T, Jacquier V, Romero A, Amar S, Abouladze M, de Paco EG, Gadacha OK, Requirand G, Robert N, Zellagui ML, de Boussac H, Cartron G, Chiche J, Ricci JE, Herbaux C, Rodriguez R, Moreaux J, Bret C.   +20 more
europepmc   +1 more source

Beyond blood transfusions: exploring iron chelation therapies in transfusion-dependent beta-thalassemia. [PDF]

Ann Med Surg (Lond)
Talha M, Ali MH, Hurjkaliani S, Rahmat ZS, Sadia H, Hasibuzzaman MA, Uzair AUQ.   +6 more
europepmc   +1 more source

Iron chelators in breast cancer therapy: mechanisms and clinical applications - a narrative review. [PDF]

Ann Med Surg (Lond)
Obeagu EI, Ngwoke AO, Malunga G.
europepmc   +1 more source

Successful case of deferasirox slow desensitization in adults. [PDF]

Allergol Select
Basa Akdogan B, Koca Kalkan I, Koycu Buhari G, Ozdedeoğlu O, Ates H, Aksu K, Oner Erkekol F.   +6 more
europepmc   +1 more source

CYP2C8-Mediated Drug-Drug Interactions and the Factors Influencing the Interaction Magnitude. [PDF]

Drug Des Devel Ther
Zhu LL, Yu LY, Wang YH, Zhou Q.
europepmc   +1 more source

Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial. [PDF]

Lancet Reg Health Southeast Asia
Premawardhena A, Wanasinghe S, Perera C, Wijethilaka MN, Rajakaruna RHMG, Samarasinghe RANKK, Williams S, Mettananda S.   +7 more
europepmc   +1 more source

<i>Candida albicans</i> enhances iron uptake to maintain fluconazole resistance. [PDF]

Infect Immun
Sharma R, Nahar A, Puri S.
europepmc   +1 more source

Comparison of the effects of deferasirox film-coated tablets (Jadenu^®) and deferasirox dispersible tablets (Exjade^®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles. [PDF]

Front Pharmacol
Mobinikhaledi M, Falahati V, Tajerian A, Hashiani AA, Ghaffari K, Ghasemi A.   +5 more
europepmc   +1 more source